Table 2.

Breathing-related complications of COVID-19 encountered by the acute respiratory disease support team

PathologyMain learning to consider
ARDS
  • Mortality benefit with dexamethasone and IL6 inhibitors

Evolving lung fibrosis
  • Methylprednisolone therapy

  • No recurrent respiratory tract infection

  • ARDS = acute respiratory distress syndrome; COVID-19 = Coronavirus disease 2019 IL6 = Interleukin 6.